Therapy devices market grows due to chronic diseases, aging population, and demand for home-based, non-drug treatment solutions.
The therapy devices market size accounted for USD 48.7 billion in 2025 and is predicted to increase from USD 52.55 billion in 2026 to approximately USD 104.17 billion by 2035, expanding at a CAGR of 7.9% from 2026 to 2035. Increasing prevalence of chronic diseases such as diabetes, arthritis, and cardiovascular issues, an aging worldwide population, and a shift toward home-driven, non-pharmacological care, which drives the growth of the therapy devices market.
Therapeutic devices are tools or apparatuses designed to treat, diagnose, or prevent disease as well as to maintain or restore health. A broad range of therapeutic tools, like ventilators, pacemakers, pumps, and stimulators are used to assist or replace certain biological functions as well as administer medication at a specified schedule or deliver therapy. A therapeutic device is any device or product that aims to offer a therapeutic advantage, which characteristically means alleviating or treating a healthcare condition.
Innovations in advanced therapy devices such as wearable technology, virtual reality, tele-rehabilitation, and robotic-driven therapy are game-changers. Therapy devices are experiencing a noteworthy revolution as evolving technologies reshape how clinicians assess, treat, and monitor patient progress. These developments in therapy go beyond added suitability; they are essentially improving results by allowing more precise diagnostics, adapted rehabilitation plans, and data-driven clinical decision-making.
| Financial year | FDI inflows (in crore ?) |
| 2023-24 | 3,978 |
| 2024-25 | 5,253 |
| 2025-26 (up to December, 2025) | 2,944 |
North America led the therapy devices market with 36% share in 2025 because of thehigh prevalence of chronic, cardiovascular, and musculoskeletal diseases requiring advanced treatment. The region's dominance is driven by robust healthcare infrastructure, rapid adoption of AI-powered and remote monitoring technologies, and high investments in R&D, alongside supportive government initiatives and growing consumer awareness regarding advanced non-invasive therapeutic options.
Asia Pacific captured 24% of the market share in 2025, and is estimated to grow at the fastest CAGR of 9.20% during the forecast period because of rapid digital transformation, increasing smartphone penetration, and rising adoption of fintech solutions across emerging economies. Furthermore, heavy government investments in infrastructure, growing consumer demand for digital services, and a shift toward electronic payment systems are fueling high-volume expansion in the region.
The top five companies in this group dominate the therapy devices market. Meanwhile, Philips launched IntraSight Plus to streamline coronary interventions and advance accurate care. Medtronic is integrating therapeutic brain-computer interface (BCI) technology in the DBS therapy. Novo Nordisk launched a multi-month subscription program. Neupulse Secures £3m spending to speed up the commercial launch of Tourette's Therapy Device. Boston Scientific is providing the Watchman device for stroke prevention.
By Product Type
By Applications
By End User
By Modality
By Technology
By Distribution Channel
By Region
Speak with a healthcare analyst about your research, consulting, or platform needs.